Stay updated on Pediatric Dulaglutide Study in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Pediatric Dulaglutide Study in Type 2 Diabetes Clinical Trial page.

Latest updates to the Pediatric Dulaglutide Study in Type 2 Diabetes Clinical Trial page
- Check5 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating access to the study record is blocked.SummaryDifference0.5%

- Check12 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study details with an access-denied message.SummaryDifference19%

- Check19 days agoChange DetectedRevision label updated from v3.6.6 to v3.7.0, signaling a software update rather than a change to the study details. The update likely includes backend or UI improvements without altering the displayed study information.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page now displays a new revision tag, v3.6.6, replacing the previous v3.6.5. This indicates a minor software version or publishing update rather than changes to the study information.SummaryDifference0.0%

- Check40 days agoChange DetectedAn NIH funding line was added to the study record, clarifying U.S. NIH support for the AWARD-PEDS trial.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page shows a new Revision: v3.6.5, replacing v3.6.4, indicating a small update to the site's release rather than a change to study information.SummaryDifference0.0%

Stay in the know with updates to Pediatric Dulaglutide Study in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Dulaglutide Study in Type 2 Diabetes Clinical Trial page.